The Biosimilars LatAm – Colombia 2023
The forum’s goal this year is to deepen the Search for public-private partnerships between government and pharmaceutical companies for the production of biosimilars focusing on the efforts that have been made by the National Government at the head of the public sector and private industries; aimed at exploring alliances in search of technology transfers that allow the production of vaccines, biosimilars, development of technology for cancer among others.
These alliances are not new in the region, they are well known in Brazil as Partnerships for Productive Development (PPD) and recently in Mexico they have been implemented for the production of Covid vaccines; which suggests a trend in the region in search of expansion, development and investment that will ultimately benefit patients with the introduction of therapeutic options that can help to overcome the access disparities that our region and Colombia currently has.
Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Program at a Glance
Regulatory Updates (INVIMA)
Regulatory and Market Facts to Ingress into the Local Market
Local Research Initiatives
Round table. INVIMA & Local Producers.
Health Authorities Success in LatAm
Full programme in the PDF Agenda
Download Agenda
Photo Gallery from Previous Events
Testimonials
-
”It was an excellent opportunity to hear what the authorities industry, even sometimes what our competitors or other providers have to say about the topic.”
Alison Bascou, Sr. Regulatory Director at BD, France
-
"I think it's being an interesting event. Wherever there's discussion at top level, wherever there's respect. wherever there's an open forum, science can advance. It's very important to keep patient's well-being in mind and I think this forum allows that."
Jaime Uribe, CEO At PROBIOMED
-
“The strength of the biosimilar industry in our region is very encouraging. It seems to me this event is the propitious forum to share experiences and it is great.”
Tammy Boggiano Ayo, Process Development Director at CIM, Cuba
-
“It showed a broad picture, from a highly technical perspective up to a commercial viewpoint. It is not easy to get that in such a short period of time.”
Santiago Salguero, Executive Director at Pharmaceutical Association of Ecuador
-
“For companies like those I work for, i.e. suppliers to the pharmaceutical industry, this has been a great opportunity to see our clients’ perspective and above all to identify the major trends determining the future of biosimilars.”
Mauricio Roberto Hernández Morales, Key Account and Business Developer Manager at BD Mexico